Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| EVP, Chief Revenue Officer | Feld Michael | Aug 26, 2026 | Sell | $31.1K | 165 |
| CEO | Polen Thomas E Jr | Aug 13, 2026 | Sell | $768.12K | 4,152 |
| EVP and President, EMEA | Goette Roland | Aug 11, 2026 | Sell | $440.89K | 2,438 |
| EVP, Chief Revenue Officer | Feld Michael | Jul 27, 2026 | Sell | $11.78K | 75 |
| EVP, Chief Revenue Officer | Feld Michael | Jun 26, 2026 | Sell | $11.46K | 75 |
| EVP & Pres Med.Essntl&BioPharm | Garrison Michael David | Jun 24, 2026 | Sell | $160.23K | 1,100 |
| EVP & Pres Med.Essntl&BioPharm | Garrison Michael David | Jun 10, 2026 | Sell | $166.63K | 1,100 |
| CEO | Polen Thomas E Jr | Jun 1, 2026 | Sell | $404.51K | 2,764 |
| EVP, Chief Revenue Officer | Feld Michael | May 26, 2026 | Sell | $11.05K | 75 |
| EVP, Chief Revenue Officer | Feld Michael | Apr 27, 2026 | Sell | $11.24K | 74 |
| EVP, Chief Revenue Officer | Feld Michael | Mar 26, 2026 | Sell | $11.76K | 75 |
| EVP, Chief Revenue Officer | Feld Michael | Feb 26, 2026 | Sell | $13.64K | 75 |
| Director | SCOTT BERTRAM L | Feb 18, 2026 | Sell | $174.03K | 953 |
| EVP, CRO & Pres. Life Sciences | Feld Michael | Jan 26, 2026 | Sell | $15.2K | 75 |
| EVP & Pres Med.Essntl&BioPharm | Garrison Michael David | Jan 15, 2026 | Sell | $125.4K | 600 |
| EVP & Pres Med.Essntl&BioPharm | Garrison Michael David | Jan 15, 2026 | Sell | $208.61K | 1,010 |
| EVP, CRO & Pres. Life Sciences | Feld Michael | Dec 26, 2025 | Sell | $14.51K | 74 |
| EVP & Pres Med.Essntl&BioPharm | Garrison Michael David | Dec 17, 2025 | Sell | $123.3K | 629 |
| EVP, CRO & Pres. Life Sciences | Feld Michael | Dec 1, 2025 | Sell | $14.5K | 75 |
| Director | SCOTT BERTRAM L | Nov 7, 2025 | Sell | $38.32K | 217 |
| EVP & President, Life Sciences | Feld Michael | Oct 27, 2025 | Sell | $10.6K | 57 |
| EVP & President, Life Sciences | Feld Michael | Sep 26, 2025 | Sell | $10.5K | 58 |
| Director | Fraser Claire | Sep 10, 2025 | Sell | $171.94K | 917 |
| EVP & President, Life Sciences | Feld Michael | Aug 22, 2025 | Sell | $11.29K | 57 |
| Director | HAYES GREGORY | Aug 11, 2025 | Buy | $1.01M | 5,250 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
